Acute Effect of Functional Crackers on Postprandial Metabolism (Crade23)

November 29, 2023 updated by: University of the Aegean

The Acute Effect of Functional Crackers, Enriched With Grape Seed Flour or With Barley Flour and β-glucans, on Postprandial Glycemic, Lipemic and Antioxidant Metabolism

The aim of this interventional study was to investigate the postprandial effect of two types of functional crackers, with 10% grape seed flour or 40% barley flour, enriched with β-glucan, in metabolic biomarkers of healthy participants.

Study Overview

Detailed Description

A pilot cross-over, controlled, randomized and single-blinded, intervention-clinical trial was carried out, in twelve healthy men and women, aged nineteen to sixty-five years, after random allocation into the control, the grape and the barley interventional groups, received a high-fat and high-carbohydrate meal, containing wheat flour or wheat and 10% grape seed flour or wheat and 40% barley flour, enriched with β-glucan, crackers. Participants consumed the same meals, allocating in cross-over order, with 1 washout week after each trial period. Differences on the metabolism of postprandial serum total, High Density Lipoprotein (HDL-), Low Density Lipoprotein (LDL-) cholesterol, glucose, triglycerides and uric acid levels, as well as of plasma total antioxidant capacity according to Ferric Reducing Antioxidant Power method, were determined between groups in fasting, thirty minutes, one and a half hour, and three hours after meal intake.

Study Type

Interventional

Enrollment (Actual)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Limnos/Lesvos
      • Myrina, Limnos/Lesvos, Greece, 81 400
        • University of the Aegean

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 19-65 years

Exclusion Criteria:

  • Age over 65 years old
  • History of chronic illness including type I and II diabetes (hemoglobin A1c-HbA1c > 5%)
  • Abnormal Body Mass Index (BMI) (>25 kg/m2)
  • Alcohol overconsumption (>40 g alcohol/day)
  • Abnormal hematological and biochemical profiles (cholesterol > 6.8 mM, triglycerides > 2.8 mM, glucose > 6.11 mM)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Grape seed flour crackers
Volunteers consumed 80g of white bread, 30g of full fat butter and 55g of wheat flour crackers, enriched with 10% grape seed flour crackers.
The crackers was enriched with 10% grape seed flour
Other Names:
  • Grape seed flour crackers
Other: Barley flour and β-glucan crackers
Volunteers consumed 80g of white bread, 30g of full fat butter and 55g of 60% wheat flour and 40% barley flour crackers, enriched with β-glucan
The crackers consisted of 60% wheat flour, 40% barley flour and was enriched with β-glucans.
Other Names:
  • Barley flour crackers
No Intervention: Control wheat crackers
Volunteers consumed 80g of white bread, 30g of full fat butter and 55g of wheat flour crackers.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glucose
Time Frame: 3 hours
Glucose concentration changes from baseline at 3hours
3 hours
Total Antioxidant Capacity
Time Frame: 3 hours
Total Antioxidant Capacity concentration changes from baseline at 3 hours
3 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total cholesterol
Time Frame: 3 hours
Total cholesterol concentration changes from baseline at 3hours
3 hours
High Density Lipoprotein cholesterol
Time Frame: 3 hours
High Density Lipoprotein concentration cholesterol changes from baseline at 3hours
3 hours
Low Density Lipoprotein cholesterol
Time Frame: 3 hours
Low Density Lipoprotein cholesterol concentration changes from baseline at 3hours
3 hours
Triglycerides
Time Frame: 3 hours
Triglycerides concentration changes from baseline at 3hours
3 hours
Uric Acid
Time Frame: 3 hours
Uric Acid concentration changes from baseline at 3hours
3 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Antonios Koutelidakis, Professor, University of the Aegean

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2023

Primary Completion (Actual)

October 1, 2023

Study Completion (Estimated)

January 15, 2024

Study Registration Dates

First Submitted

July 16, 2023

First Submitted That Met QC Criteria

July 26, 2023

First Posted (Actual)

August 4, 2023

Study Record Updates

Last Update Posted (Actual)

November 30, 2023

Last Update Submitted That Met QC Criteria

November 29, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There are no plans to share individual participant data for this study.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Functional crackers enriched with grape seed flour

Subscribe